Stay updated on Pediatric Galcanezumab for Episodic Migraine Clinical Trial
Sign up to get notified when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.

Latest updates to the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page
- Check6 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.4.2 entry was added to the page history. The government funding lapse notice and the prior Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a site-wide funding-lapse notice and updated the record revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check49 days agoChange DetectedDifference0.6%

- Check56 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3. This is a minor site revision update that does not affect the study record or its data.SummaryDifference0.0%

- Check84 days agoChange DetectedFooter now shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and the Revision: v3.3.2 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pediatric Galcanezumab for Episodic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.